Outcome reliability in non-Ambulatory Boys/Men with duchenne muscular dystrophy

Muscle and Nerve

Volumn 51, Issue 4, 2015, Pages 522-532

  Connolly, Anne M ^a   Malkus, Elizabeth C ^a   Mendell, Jerry R ^b   Flanigan, Kevin M ^b   Miller, J Philip ^a   Schierbecker, Jeanine R ^a   Siener, Catherine A ^a   Golumbek, Paul T ^a   Zaidman, Craig M ^a   Mcdonald, Craig M ^c   Johnson, Linda ^c   Nicorici, Alina ^c   Karachunski, Peter I ^d   Day, John W ^e   Kelecic, Jason M ^e   Lowes, Linda P ^b   Alfano, Lindsay N ^b   Darras, Basil T ^f   Kang, Peter B ^g   Quigley, Janet ^f   Pasternak, Amy E ^f   Florence, Julaine M ^a   Anand, Pallavi ^a   Wulf, Charlie O ^a   Goude, Erica ^a   Dalton, Joline C ^d   Viollet Callendret, Laurence ^b   Buser, Karen K ^d   Shriber, Elizabeth ^h,i   Parad, Rebecca ^h,i   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h HARVARD UNIVERSITY   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Corticosteroids; Duchenne muscular dystrophy; Non ambulatory; Pulmonary function; Quality of life; Strength

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASSISTED VENTILATION; BODY MASS; BROOKE UPPER EXTREMITY FUNCTIONAL RATING; CAREGIVER BURDEN; CORTICOSTEROID THERAPY; DUCHENNE MUSCULAR DYSTROPHY; EXPERIMENTAL THERAPY; FEASIBILITY STUDY; FEMALE; FLEXION CONTRACTURE; FORCED VITAL CAPACITY; GONIOMETRY; GRIP STRENGTH; HUMAN; HUMAN TISSUE; IMMOBILITY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCULOSKELETAL DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PINCH STRENGTH; PRIORITY JOURNAL; RANGE OF MOTION; RELIABILITY; TASK PERFORMANCE; ADOLESCENT; CHILD; DISABILITY; HAND; INNERVATION; MUSCULAR DYSTROPHY, DUCHENNE; PATHOPHYSIOLOGY; REPRODUCIBILITY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CHILD; DISABILITY EVALUATION; HAND; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84925350947     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24346     Document Type: Article

References (52)

1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-928.
2. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007;17:290-296.
3. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002;12:926-929.
4. Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 2007;1772:229-237.
5. Lebel DE, Corston JA, McAdam LC, Biggar WD, Alman BA. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up. J Bone Joint Surg Am 2013;95:1057-1061.
6. Smith PE, Edwards RH, Calverley PM. Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy. Chest 1989;96:1346-1351.
7. Smith PE, Calverley PM, Edwards RH. Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988;137:884-888.
8. Phillips MF, Quinlivan RC, Edwards RH, Calverley PM. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001;164:2191-2194.
9. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000;29:141-150.
10. Mayhew JE, Florence JM, Mayhew TP, Henricson EK, Leshner RT, McCarter RJ, et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve 2007;35:36-42.
11. McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995;74(suppl):S70-92.
12. Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE. Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 2009;80:320-325.
13. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
14. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 1989;39:475-481.
15. Steffensen B, Hyde S, Lyager S, Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int 2001;6:119-134.
16. Brunherotti MA, Sobreira C, Rodrigues-Junior AL, de Assis MR, Terra Filho J, Baddini Martinez JA. Correlations of Egen Klassifikation and Barthel Index scores with pulmonary function parameters in Duchenne muscular dystrophy. Heart Lung 2007;36:132-139.
17. Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992;72:115-122.
18. Escolar DM, Henricson EK, Mayhew J, Florence J, Leshner R, Patel KM, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001;24:787-793.
19. Diniz GP, Lasmar LM, Giannetti JG. Motor assessment in patients with Duchenne muscular dystrophy. Arq Neuropsiquiatr 2012;70:416-421.
20. Stuberg WA, Metcalf WK. Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. Phys Ther 1988;68:977-982.
21. Lerario A, Bonfiglio S, Sormani M, Tettamanti A, Marktel S, Napolitano S, et al. Quantitative muscle strength assessment in Duchenne muscular dystrophy: longitudinal study and correlation with functional measures. BMC Neurol 2012;12:91.
22. Mattar FL, Sobreira C. Hand weakness in Duchenne muscular dystrophy and its relation to physical disability. Neuromuscul Disord 2008;18:193-198.
23. Jebsen RH, Taylor N, Trieschmann RB, Trotter MJ, Howard LA. An objective and standardized test of hand function. Arch Phys Med Rehabil 1969;50:311-319.
24. Hiller LB, Wade CK. Upper extremity functional assessment scales in children with Duchenne muscular dystrophy: a comparison. Arch Phys Med Rehabil 1992;73:527-534.
25. Wagner MB, Vignos PJ Jr, Carlozzi C, Hull AL. Assessment of hand function in Duchenne muscular dystrophy. Arch Phys Med Rehabil 1993;74:801-804.
26. Immerman I, Alfonso DT, Ramos LE, Grossman LA, Alfonso I, Ditaranto P, et al. Hand function in children with an upper brachial plexus birth injury: results of the nine-hole peg test. Dev Med Child Neurol 2012;54:166-169.
27. Poole JL, Burtner PA, Torres TA, McMullen CK, Markham A, Marcum ML, et al. Measuring dexterity in children using the Nine-hole Peg Test. J Hand Ther 2005;18:348-351.
28. Oxford Grice K, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther 2003;57:570-573.
29. Smith YA, Hong E, Presson C. Normative and validation studies of the Nine-hole Peg Test with children. Percept Mot Skills 2000;90:823-843.
30. Hayes K, Walton JR, Szomor ZR, Murrell GA. Reliability of five methods for assessing shoulder range of motion. Aust J Physiother 2001;47:289-294.
31. Boone DC, Azen SP, Lin CM, Spence C, Baron C, Lee L. Reliability of goniometric measurements. Phys Ther 1978;58:1355-1360.
32. Pandya S, Florence JM, King WM, Robison JD, Oxman M, Province MA. Reliability of goniometric measurements in patients with Duchenne muscular dystrophy. Phys Ther 1985;65:1339-1342.
33. Davis SE, Hynan LS, Limbers CA, Andersen CM, Greene MC, Varni JW, et al. The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. J Clin Neuromuscul Dis 2010;11:97-109.
34. Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 2007;68:1051-1057.
35. Mercuri E, McDonald C, Mayhew A, Florence J, Mazzone E, Bianco F, et al. International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy: Rome, 15-16 February 2012. Neuromuscul Disord 2012;22:1025-1028.
36. Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol 2013;55:1038-1045.
37. Mazzone ES, Vasco G, Palermo C, Bianco F, Galluccio C, Ricotti V, et al. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol 2012;54:879-885.
38. Kurillo G, Han JJ, Abresch RT, Nicorici A, Yan P, Bajcsy R. Development and application of stereo camera-based upper extremity workspace evaluation in patients with neuromuscular diseases. PLoS One 2012;7:e45341.
39. Servais L, Deconinck N, Moraux A, Benali M, Canal A, van Parys F, et al. Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients. Neuromuscul Disord 2013;23:139-148.
40. Gauld LM, Kappers J, Carlin JB, Robertson CF. Prediction of childhood pulmonary function using ulna length. Am J Respir Crit Care Med 2003;168:804-809.
41. Gauld LM, Boynton A. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 2005;39:457-460.
42. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
43. Lue YJ, Su CY, Yang RC, Su WL, Lu YM, Lin RF, et al. Development and validation of a muscular dystrophy-specific functional rating scale. Clin Rehabil 2006;20:804-817.
44. Mendell JR, Florence J. Manual muscle testing. Muscle Nerve 1990;13(suppl):S16-20.
45. Mulcahey MJ, Smith BT, Betz RR, Weiss AA. Outcomes of tendon transfer surgery and occupational therapy in a child with tetraplegia secondary to spinal cord injury. Am J Occup Ther 1995;49:607-617.
46. Noronha J, Bundy A, Groll J. The effect of positioning on the hand function of boys with cerebral palsy. Am J Occup Ther 1989;43:507-512.
47. Kang SW, Kang YS, Sohn HS, Park JH, Moon JH. Respiratory muscle strength and cough capacity in patients with Duchenne muscular dystrophy. Yonsei Med J 2006;47:184-190.
48. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. IPPB-assisted coughing in neuromuscular disorders. Pediatr Pulmonol 2006;41:551-557.
49. Alman BA, Raza SN, Biggar WD. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy. J Bone Joint Surg Am 2004;86-A:519-524.
50. Connolly AM, Kim HJ, Bridwell KH. Corticosteroids can reduce the severity of scoliosis in Duchenne muscular dystrophy. J Bone Joint Surg Am 2013;95:e86.
51. Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol 2013;73:481-488.
52. Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, et al. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 2011;76:219-226.